Literature DB >> 6299027

[Antibacterial effects of niridazole. II. Effects on aerobic and anaerobic bacteria].

H Hof, K M Müller.   

Abstract

Niridazole which is chemically related to metronidazole is endowed with much better antibacterial activity. First, several genera of aerobic bacteria, such as Salmonella and Escherichia, are susceptible to niridazole, whereas metronidazole is completely ineffective. There exist, however, some particular strains which are naturally resistant to niridazole. The in vitro activity of niridazole is still increased, if these facultative anaerobic bacteria are tested under anaerobic growth conditions. Second, niridazole has a higher in vitro activity against anaerobic bacteria, such as Bacteroides spp., Clostridium spp., Fusobacterium spp. and Peptococcus sp., than metronidazole. Extremely low MIC values of niridazole were found ranging from 0.0037 to 0.06 microgram/ml. Propionibacterium acnes, which are resistant to the action of metronidazole, are also relatively resistant to niridazole.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6299027

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Mikrobiol Hyg A        ISSN: 0174-3031


  4 in total

1.  Antibacterial effects of niridazole: its effect on microaerophilic campylobacter.

Authors:  H Hof; V Sticht-Groh
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

2.  Effect of different nitroheterocyclic compounds on aerobic, microaerophilic, and anaerobic bacteria.

Authors:  H Hof; J Ströder; J P Buisson; R Royer
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

3.  Antibacterial activities of nitrothiazole against Campylobacter jejuni and Campylobacter coli.

Authors:  H Hof; M Rieffert; V Sticht-Groh; O Zak; E H Schweizer
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

4.  Antibacterial activity of niridazole against Salmonellae.

Authors:  R M Bannatyne; J Jackowski; R B Grant
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.